| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 1 203-209, Copyright © 1995 by American Association of Immunologists
ARTICLES |
J Kennedy, GS Kelner, S Kleyensteuber, TJ Schall, MC Weiss, H Yssel, PV Schneider, BG Cocks, KB Bacon and A Zlotnik
Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA.
We describe the isolation of a cDNA that encodes human lymphotactin (Ltn), a new class of lymphocyte-specific chemokine. Human Ltn shows similarity to some members of the C-C chemokine family but has lost the first and third cysteine residues that are characteristic of the C-C and C-X-C chemokines. Ltn is chemotactic for lymphocytes but not for monocytes, a characteristic that makes it unique among chemokines. In addition, calcium flux desensitization studies indicate that Ltn uses a unique receptor. The human Ltn gene maps to a different chromosome than do the C-C and C-X-C chemokine families. Taken together, these characteristics indicate that Ltn is the first example of a new class of human chemokines with preferential effects on lymphocytes.
This article has been cited by other articles:
|
|
 |
|
  M. M. Zanone, E. Favaro, E. Ferioli, G. C. Huang, N. J. Klein, P. C. Perin, M. Peakman, P. G. Conaldi, and G. Camussi Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection FASEB J, October 1, 2007; 21(12): 3308 - 3317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Luttichau, A. H. Johnsen, J. Jurlander, M. M. Rosenkilde, and T. W. Schwartz Kaposi Sarcoma-associated Herpes Virus Targets the Lymphotactin Receptor with Both a Broad Spectrum Antagonist vCCL2 and a Highly Selective and Potent Agonist vCCL3 J. Biol. Chem., June 15, 2007; 282(24): 17794 - 17805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. von Hundelshausen and C. Weber Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease Circ. Res., January 5, 2007; 100(1): 27 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hashida, N. Ohguro, K. Nakai, M. Kobashi-Hashida, S.-i. Hashimoto, K. Matsushima, and Y. Tano Microarray Analysis of Cytokine and Chemokine Gene Expression after Prednisolone Treatment in Murine Experimental Autoimmune Uveoretinitis Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4224 - 4234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yokokawa, C. Palena, P. Arlen, R. Hassan, M. Ho, I. Pastan, J. Schlom, and K. Y. Tsang Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of Mesothelin Clin. Cancer Res., September 1, 2005; 11(17): 6342 - 6351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Puneet, S. Moochhala, and M. Bhatia Chemokines in acute respiratory distress syndrome Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L3 - L15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Palena, J. Schlom, and K.-Y. Tsang Differential Gene Expression Profiles in a Human T-cell Line Stimulated with a Tumor-associated Self-peptide versus an Enhancer Agonist Peptide Clin. Cancer Res., May 1, 2003; 9(5): 1616 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Rousseau, A. E. Haight, C. Hirschmann-Jax, E. S. Yvon, D. R. Rill, Z. Mei, S. C. Smith, S. Inman, K. Cooper, P. Alcoser, et al. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma Blood, March 1, 2003; 101(5): 1718 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Hoover and J. Lubkowski DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis Nucleic Acids Res., May 15, 2002; 30(10): e43 - e43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kuloglu, D. R. McCaslin, J. L. Markley, and B. F. Volkman Structural Rearrangement of Human Lymphotactin, a C Chemokine, under Physiological Solution Conditions J. Biol. Chem., May 10, 2002; 277(20): 17863 - 17870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Huang, F. Li, J. R. Gordon, and J. Xiang Synergistic Enhancement of Antitumor Immunity with Adoptively Transferred Tumor-specific CD4+ and CD8+ T Cells and Intratumoral Lymphotactin Transgene Expression Cancer Res., April 1, 2002; 62(7): 2043 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. McKee, R. Defina, H. He, K. J. Haley, J. R. Stone, and D. L. Perkins Prolonged Allograft Survival in TNF Receptor 1-Deficient Recipients Is Due to Immunoregulatory Effects, Not to Inhibition of Direct Antigraft Cytotoxicity J. Immunol., January 1, 2002; 168(1): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Middel, P. Thelen, S. Blaschke, F. Polzien, K. Reich, V. Blaschke, A. Wrede, K. M. Hummel, B. Gunawan, and H.-J. Radzun Expression of the T-Cell Chemoattractant Chemokine Lymphotactin in Crohn's Disease Am. J. Pathol., November 1, 2001; 159(5): 1751 - 1761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Cairns, J. R. Gordon, F. Li, M. E. Baca-Estrada, T. Moyana, and J. Xiang Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor J. Immunol., July 1, 2001; 167(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cerdan, E. Devilard, L. Xerri, and D. Olive The C-class chemokine lymphotactin costimulates the apoptosis of human CD4+ T cells Blood, April 15, 2001; 97(8): 2205 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Kutsch, J.-W. Oh, A. Nath, and E. N. Benveniste Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes J. Virol., October 1, 2000; 74(19): 9214 - 9221. [Abstract] [Full Text]
|
|
|
|
|
|
X. Cao, W. Zhang, T. Wan, L. He, T. Chen, Z. Yuan, S. Ma, Y. Yu, and G. Chen Molecular Cloning and Characterization of a Novel CXC Chemokine Macrophage Inflammatory Protein-2{gamma} Chemoattractant for Human Neutrophils and Dendritic Cells J. Immunol., September 1, 2000; 165(5): 2588 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cerdan, E. Serfling, and D. Olive The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4+ T cells Blood, July 15, 2000; 96(2): 420 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Murdoch and A. Finn Chemokine receptors and their role in inflammation and infectious diseases Blood, May 15, 2000; 95(10): 3032 - 3043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamagami, D. Miyazaki, S. J. Ono, and M. R. Dana Differential Chemokine Gene Expression in Corneal Transplant Rejection Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2892 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. VILA-CORO, J. M. RODRÍGUEZ-FRADE, A. MARTÍN DE ANA, M. C. MORENO-ORTÍZ, C. MARTÍNEZ-A, and M. MELLADO The chemokine SDF-1{alpha} triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway FASEB J, October 1, 1999; 13(13): 1699 - 1710. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yoshida, I. Ishikawa, Y. Ono, T. Imai, R. Suzuki, and O. Yoshie An Activation-Responsive Element in Single C Motif-1/Lymphotactin Promoter Is a Site of Constitutive and Inducible DNA-Protein Interactions Involving Nuclear Factor of Activated T Cell J. Immunol., September 15, 1999; 163(6): 3295 - 3303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhang, B.-S. Youn, J.-L. Gao, P. M. Murphy, and B. S. Kwon Differential Effects of Leukotactin-1 and Macrophage Inflammatory Protein-1{alpha} on Neutrophils Mediated by CCR1 J. Immunol., April 15, 1999; 162(8): 4938 - 4942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Lillard Jr., P. N. Boyaka, J. A. Hedrick, A. Zlotnik, and J. R. McGhee Lymphotactin Acts as an Innate Mucosal Adjuvant J. Immunol., February 15, 1999; 162(4): 1959 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Reape, K. Rayner, C. D. Manning, A. N. Gee, M. S. Barnette, K. G. Burnand, and P. H.E. Groot Expression and Cellular Localization of the CC Chemokines PARC and ELC in Human Atherosclerotic Plaques Am. J. Pathol., February 1, 1999; 154(2): 365 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. van den Berg, M. C. Faber-Krol, R. B. Sim, and M. R. Daha The First Subcomponent of Complement, C1q, Triggers the Production of IL-8, IL-6, and Monocyte Chemoattractant Peptide-1 by Human Umbilical Vein Endothelial Cells J. Immunol., December 15, 1998; 161(12): 6924 - 6930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Engelhardt, A. Toksoy, M. Goebeler, S. Debus, E.-B. Brocker, and R. Gillitzer Chemokines IL-8, GRO{alpha}, MCP-1, IP-10, and Mig Are Sequentially and Differentially Expressed During Phase-Specific Infiltration of Leukocyte Subsets in Human Wound Healing Am. J. Pathol., December 1, 1998; 153(6): 1849 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cao, W. Zhang, L. He, Z. Xie, S. Ma, Q. Tao, Y. Yu, H. Hamada, and J. Wang Lymphotactin Gene-Modified Bone Marrow Dendritic Cells Act as More Potent Adjuvants for Peptide Delivery to Induce Specific Antitumor Immunity J. Immunol., December 1, 1998; 161(11): 6238 - 6244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshida, T. Imai, M. Kakizaki, M. Nishimura, S. Takagi, and O. Yoshie Identification of Single C Motif-1/Lymphotactin Receptor XCR1 J. Biol. Chem., June 26, 1998; 273(26): 16551 - 16554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Cole, C. A. Strick, T. J. Paradis, K. T. Ogborne, M. Loetscher, R. P. Gladue, W. Lin, J. G. Boyd, B. Moser, D. E. Wood, et al. Interferon-inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 J. Exp. Med., June 15, 1998; 187(12): 2009 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. GRIMM, A. BEN-BARUCH, D. D. TAUB, O. M. Z. HOWARD, J. M. WANG, and J. J. OPPENHEIM Opiate Inhibition of Chemokine-Induced Chemotaxis Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 9 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Dairaghi, K. Franz-Bacon, E. Callas, J. Cupp, T. J. Schall, S. A. Tamraz, S. A. Boehme, N. Taylor, and K. B. Bacon Macrophage Inflammatory Protein-1beta Induces Migration and Activation of Human Thymocytes Blood, April 15, 1998; 91(8): 2905 - 2913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Bacon, T. J. Schall, and D. J. Dairaghi RANTES Activation of Phospholipase D in Jurkat T Cells: Requirement of GTP-Binding Proteins ARF and RhoA J. Immunol., February 15, 1998; 160(4): 1894 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dorner, S. Muller, F. Entschladen, J. M. Schroder, P. Franke, R. Kraft, P. Friedl, I. Clark-Lewis, and R. A. Kroczek Purification, Structural Analysis, and Function of Natural ATAC, a Cytokine Secreted by CD8+ T Cells J. Biol. Chem., March 28, 1997; 272(13): 8817 - 8823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hieshima, T. Imai, G. Opdenakker, J. Van Damme, J. Kusuda, H. Tei, Y. Sakaki, K. Takatsuki, R. Miura, O. Yoshie, et al. Molecular Cloning of a Novel Human CC Chemokine Liver and Activation-regulated Chemokine (LARC) Expressed in Liver. CHEMOTACTIC ACTIVITY FOR LYMPHOCYTES AND GENE LOCALIZATION ON CHROMOSOME 2 J. Biol. Chem., February 28, 1997; 272(9): 5846 - 5853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Ahuja and P. M. Murphy The CXC Chemokines Growth-regulated Oncogene (GRO) alpha , GRObeta , GROgamma , Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor J. Biol. Chem., August 23, 1996; 271(34): 20545 - 20550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Szabo, K. S. Soo, A. Zlotnik, and T. J. Schall Chemokine Class Differences in Binding to the Duffy Antigen-Erythrocyte Chemokine Receptor J. Biol. Chem., October 27, 1995; 270(43): 25348 - 25351. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
